PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
61.62%
Net income growth 1.25-1.5x META's 51.53%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
2.72%
Some D&A expansion while META is negative at -0.35%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
123.01%
Some yoy growth while META is negative at -803.74%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-5.53%
Negative yoy SBC while META is 1.59%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-67.51%
Negative yoy working capital usage while META is 101.23%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-4401.25%
Both yoy AR lines negative, with META at -209.02%. Martin Whitman would suspect an overall sector lean approach or softer demand.
172.57%
Inventory growth well above META's 103.90%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
187.67%
AP growth well above META's 348.21%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-76.40%
Negative yoy usage while META is 106.26%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-23.06%
Both negative yoy, with META at -83.72%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
21.51%
Operating cash flow growth below 50% of META's 153.43%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-0.28%
Both yoy lines negative, with META at -13.33%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
92.12%
Some acquisitions while META is negative at -1679.35%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-51.63%
Both yoy lines negative, with META at -128.68%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
31.83%
1.25-1.5x META's 24.21%. Bruce Berkowitz sees a sizable advantage unless competitor’s portfolio yields future gains.
-441.18%
We reduce yoy other investing while META is 98.78%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-79.89%
Both yoy lines negative, with META at -297.39%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-74.29%
Both yoy lines negative, with META at -73.39%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
-15.25%
Both yoy lines negative, with META at -26.10%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.